Share

Jinyu Bio-technology Co., Ltd. Stocks

CN¥ 14.8Last Updated 12.03.2026

Issuer Rating

4/7

Performance

Poor

Risk

Low

Recommendation

Hold

Market Cap

CN¥ 2.45B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 14.8
Key Takeaways

Risk factor

Strong trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable price performance

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sales of veterinary biological products in China. It offers vaccines for foot-and-mouth disease, highly pathogenic avian influenza, brucellosis, rabies, and swine fever for pigs, poultry, ruminants, and pets. The company was formerly known as Inner Mongolia Jinyu Group Co., Ltd. and changed its...

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks